US Patent 8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics

US Patent 12121565 Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies

US Patent 12103931 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy

US Patent 12077554 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

US Patent 12076375 Treating and preventing

US Patent 12071465 Methods of making and using extracellular domain-based chimeric proteins

US Patent 12064418 Conjoint therapies for immunomodulation

US Patent 12006366 Methods and compositions for preventing type 1 diabetes

US Patent 11999743 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

US Patent 11993653 Antibodies and methods of use thereof

US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof

US Patent 11981922 Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment

US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment

US Patent 11970500 Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

US Patent 11957695 Methods and compositions targeting glucocorticoid signaling for modulating immune responses

US Patent 11939306 Crystal forms of immunomodulators

US Patent 11938192 Dosage regimes for the administration of an anti-CD19 ADC

US Patent 11912746 PD-1 homing endonuclease variants, compositions, and methods of use

US Patent 11905329 Anti-PD-1 antibodies and uses thereof

US Patent 11905322 Engineered PD-1 variants